Technical analysis of Shuttle Pharmaceuticals Holdings, Inc. (SHPH): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Price Performance
| 1 month | -20.15% |
| 3 months | -9.54% |
| Year-to-date | -82.61% |
| 1 year | -92.82% |
| 3 years | -99.76% |
52-Week Range
| 52-week High | $55.90 |
| 52-week Low | $2.58 |
| Avg Volume (90d) | 1.5M |
Technical Indicators
| SMA 50 | $3.57 |
| SMA 200 | $9.09 |
| 30-day Volatility (annualised) | 106.1% |
| Price vs SMA 50 | -12.3% |
| Price vs SMA 200 | -65.6% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $29.70 | |
| 2025-11 | $14.30 | -51.9% |
| 2025-12 | $18.00 | +25.9% |
| 2026-01 | $20.20 | +12.2% |
| 2026-02 | $10.00 | -50.5% |
| 2026-03 | $6.79 | -32.1% |
| 2026-04 | $10.30 | +51.7% |
| 2026-05 | $5.25 | -49.0% |
| 2026-06 | $3.25 | -38.1% |
| 2026-07 | $3.80 | +16.9% |
| 2026-08 | $3.36 | -11.6% |
| 2026-09 | $3.13 | -6.8% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $3.13 |
| Market Cap | $2M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.47 |
| EV / EBITDA | -0.12 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.06 |
| Current Ratio | 0.30 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -10.78 |